THYROCAREThyrocare Technologies Limited
Convert to ideaHealthcare · Healthcare Services
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeDown 0.4 this quarter.
Momentum from moving averages, Supertrend and RSI.
2 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
2 found · risk elevated
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹271 Cr | ₹15 Cr | 27.98% | 5.62% | ₹0.96 | 21.9x |
| Q1 FY2027 | ₹240 Cr | ₹51 Cr | 26.99% | 21.39% | ₹3.23 | 51.1x |
| Q4 FY2026 | ₹224 Cr | ₹49 Cr | 27.27% | 21.75% | ₹2.99 | 43.0x |
| Q3 FY2026 | ₹196 Cr | ₹28 Cr | 18.51% | 14.35% | ₹1.82 | N/A |
| Q2 FY2026 | ₹217 Cr | ₹48 Cr | 27.64% | 22.08% | ₹3.02 | 106.6x |
| Q1 FY2026 | ₹193 Cr | ₹38 Cr | 24.02% | 19.84% | ₹2.45 | 65.4x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Healthcare Services
Compare with peers →Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.